Product Datasheet

 
Product Description
 
Product: Kininogen, LMW, Human Plasma
Catalog Number: HK-LMW
Product Page: https://www.mol-innov.com/products/IHUKNGSCHMW100UG
Description: LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.
Recommended Storage: SAMPLE
Minimum Shelf Life: 232.75
Source: Lyophilized
Molecular Weight: Proteins
Extinction Coefficient: 65,000
Antigen: -70 C
Target: Lyophilized powder
Target Molecular Weight: KININOGEN
Host: 679.25
Clonality: 5
Isotype: Human plasma
Applications: Cold pack
Cross-reactivity: 3 years from delivery
Concentration: 245
Volume: 715
Titer: 0.01M Sodium Acetate; 0.25M NaCl; pH 5.5
Buffer: SAMPLE
Form: 0.1 mg
 
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet.
 
For in vitro laboratory use only
 
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com